House Energy and Commerce Committee Republican Leader Greg Walden (R-OR) lauded the actions of President Donald Trump in extending the fentanyl analogues ban.
Trump recently signed the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act (S. 3201) into law, which created the ban extension.
The bill, introduced by Sen. Lindsey Graham (R-SC), extends the temporary scheduling order for fentanyl-related substances.
“President Donald Trump is following through with his ‘unyielding commitment’ at the State of the Union to combat the opioid crisis,” Walden said. “I applaud the President for signing into law this extension of a ban on fentanyl analogues. This gives law enforcement a critical tool in their fight against criminals who can change as little as one molecule to make an illegal fentanyl-related substance legal. With a potential of more than 3,000 fentanyl analogues, the importance of the DEA being able to go after all fentanyl-related substances can’t be understated.”
There are currently 12 bills working their way through Congress that address opioids. One of those 12 bills, the Stop the Importation and Manufacturing of Synthetic Analogues (SIMSA) Act, would also further efforts to fight fentanyl — a synthetic opioid.